製品の概要

  • 製品名Anti-TTC8 antibody
    TTC8 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to TTC8
  • アプリケーション適用あり: WBmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat, Rabbit, Horse, Guinea pig, Cow, Cat, Dog
  • 免疫原

    Synthetic peptide corresponding to a region within N terminal amino acids 72-121 (NAIAQVPRPG TSLKLPGTNQ TGGPSQAVRP ITQAGRPITG FLRPSTQSGR) of Human TTC8 (NP_938052).

  • ポジティブ・コントロール
    • THP-1 cell lysate.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab89710 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 60 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

ターゲット情報

  • 機能The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane.
  • 組織特異性Widely expressed.
  • 関連疾患Defects in TTC8 are the cause of retinitis pigmentosa type 51 (RP51) [MIM:613464]. It is a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
    Defects in TTC8 are the cause of Bardet-Biedl syndrome type 8 (BBS8) [MIM:209900]. Bardet-Biedl syndrome (BBS) is a genetically heterogeneous, autosomal recessive disorder characterized by usually severe pigmentary retinopathy, early onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. A relatively high incidence of BBS is found in the mixed Arab populations of Kuwait and in Bedouin tribes throughout the Middle East, most likely due to the high rate of consaguinity in these populations and a founder effect.
  • 配列類似性Contains 8 TPR repeats.
  • 細胞内局在Cytoplasm > cytoskeleton > centrosome. Cell projection > cilium membrane. Cytoplasm. Localizes to nonmembranous centriolar satellites in the cytoplasm.
  • Information by UniProt
  • 参照データベース
  • 別名
    • Bardet Biedl syndrome 8 protein antibody
    • Bardet Biedl syndrome type 8 antibody
    • Bardet-Biedl syndrome 8 protein antibody
    • BBS8 antibody
    • RP51 antibody
    • Tetratricopeptide repeat domain 8 antibody
    • Tetratricopeptide repeat protein 8 antibody
    • TPR repeat protein 8 antibody
    • TTC 8 antibody
    • Ttc8 antibody
    • TTC8_HUMAN antibody
    see all

Anti-TTC8 antibody 画像

  • Anti-TTC8 antibody (ab89710) at 1 µg/ml (in 5% skim milk / PBS buffer) + THP-1 cell lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 60 kDa

Anti-TTC8 antibody (ab89710) 使用論文

ab89710 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab89710.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"